A fake malaria drug caused a death in Myanmar recently. A patient went to a rural hospital in east Myanmar where he was diagnosed with falciparum malaria and treated with the anti-malarial drug artesunate.
The drug is usually effective, yet it led to the patient's death. The drug was reportedly manufactured by China's Guilin Pharmaceutical Company. Researchers led by Paul Newton of the University of Oxford found the artesunate tablets to be fake, containing just 20 per cent of the amount of the active agent contained in a genuine artesunate tablet. In a study in the same region where genuine artesunate was administered to falciparum malaria patients, every single patient survived. Newton and colleagues concluded the man's death was due to the fake artesunate.
Experts say counterfeit artesunate continue to circulate in large numbers in southeast Asia, where 38 per cent to 52 per cent of artesunate tablets sampled contain no active ingredient.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.